| Literature DB >> 25948820 |
Christina A Eichstaedt1, Tiago Antão2, Alexia Cardona3, Luca Pagani4, Toomas Kivisild3, Maru Mormina5.
Abstract
Highland populations living permanently under hypobaric hypoxia have been subject of extensive research because of the relevance of their physiological adaptations for the understanding of human health and disease. In this context, what is considered high altitude is a matter of interpretation and while the adaptive processes at high altitude (above 3000 m) are well documented, the effects of moderate altitude (below 3000 m) on the phenotype are less well established. In this study, we compare physiological and anthropometric characteristics as well as genetic variations in two Andean populations: the Calchaquíes (2300 m) and neighboring Collas (3500 m). We compare their phenotype and genotype to the sea-level Wichí population. We measured physiological (heart rate, oxygen saturation, respiration rate, and lung function) as well as anthropometric traits (height, sitting height, weight, forearm, and tibia length). We conducted genome-wide genotyping on a subset of the sample (n = 74) and performed various scans for positive selection. At the phenotypic level (n = 179), increased lung capacity stood out in both Andean groups, whereas a growth reduction in distal limbs was only observed at high altitude. At the genome level, Calchaquíes revealed strong signals around PRKG1, suggesting that the nitric oxide pathway may be a target of selection. PRKG1 was highlighted by one of four selection tests among the top five genes using the population branch statistic. Selection tests results of Collas were reported previously. Overall, our study shows that some phenotypic and genetic differentiation occurs at intermediate altitude in response to moderate lifelong selection pressures.Entities:
Keywords: Calchaquíes; Diaguita; lung capacity; moderate hypoxia
Year: 2015 PMID: 25948820 PMCID: PMC4463816 DOI: 10.14814/phy2.12376
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Figure 1Range of birthplaces of participants and their ancestors in the three regions. Dots on the map are roughly proportional to the number of individuals born in one location. The maximum extent is displayed as circles: 94 Calchaquí participant (IA) ancestors were born in Cachi, 43 Colla participant (HA) ancestors in San Antonio de los Cobres. Stars denote sampling locations. The third purple star from left indicates Misión Chaqueña. HA, high altitude; LA, low altitude; IA, intermediate altitude.
Figure 2Admixture proportions of Calchaquíes among Native Americans, Han Chinese, and Europeans at K = 6. Ancestry components are assigned to each individual. Cross-validation error was the lowest for K = 6, which indicates that the population structure observed among the included populations is best explained by 6 distinct ancestry components. Han Chinese, Europeans, Pima, Suruí, Andeans (HA and IA), and Wichí (LA) are characterized by a unique ancestry components; that is, the program assumes a major genetic contribution from separate ancestors for each of these populations. Mixe from Mexico, Piapoco from Colombia, Kaqchikel from Guatemala, and Karitiana from Brazil share the same four Native American admixture components in similar proportions. Chileans (Hul/Chi/Cho/Yag: Hulliche, Chilote, Chono, and Yaghan) display the same four components but the Andean ancestry component accounts for more than 50%. Populations from the Gran Chaco region other than Wichí (Cha/Kai/Gua/Tob: Chané, Kaingang, Guaraní, and Toba) share more than 30% of the Wichí ancestry component.
Autosomal admixture estimates at K = 6 in Argentineans
| Admixture | Wichí (LA), % | Calchaquíes (IA), % | Collas (HA), % |
|---|---|---|---|
| Mean | 2.7 | 8.6 | 5.0 |
| Median | 0.0 | 8.6 | 4.9 |
| Range | 0.0–20.9 | 4.1–20.7 | 0.0–9.5 |
Figure 3PCA of neighboring Andean populations. Circles denote individuals from Mao et al. (2007); triangles refer to this study, diamonds to Eichstaedt et al. (2014), and rectangles to Reich et al. (2012). (A) Samples overlap but cluster roughly according to geographic origin: populations in the left circle stem from Peru (HA), in the bottom circle from Bolivia and Chile and in the right circle from Argentina (HA and IA). Due to unknown precise sampling locations Quechua individuals sampled by Reich et al. (2012) cannot be assigned to one specific country. However, it is likely that Quechua from Peru cluster with Peruvian Quechua sampled by Mao et al. (2007) and Quechua from Bolivia overlap with Bolivian Aymara. (B) The same samples except for Quechua and Aymara from Reich et al. (2012) with unclear geographic origin were included, showing a clustering by geographic origin apart for one Peruvian Quechua individual.
Mitochondrial DNA and Y-chromosome haplogroups among Argentineans
| Marker | Haplogroup | Wichí (LA) (%) | Calchaquíes (IA) (%) | Collas (HA) (%) |
|---|---|---|---|---|
| Mitochondrial DNA | A | 0 | 0 | 1 (1.3) |
| A2 | 11 (25.0) | 9 (15.0) | 13 (17.3) | |
| B2 | 19 (43.2) | 34 (56.7) | 49 (65.3) | |
| C1 | 0 | 5 (8.3) | 4 (5.3) | |
| D1 | 14 (31.8) | 11 (18.3) | 8 (10.7) | |
| D4h3a | 0 | 1 (1.7) | 0 | |
| Y-chromosome | Q | 16 (88.9) | 16 (80.0) | 19 (73.1) |
| R1b | 2 (11.1) | 3 (15.0) | 6 (23.1) | |
| J | 0 | 0 | 1 (3.8) | |
| E1b1b1b | 0 | 1 (5) | 0 |
This haplogroup is a paragroup of A2.
Phenotypic differences between Wichí, Calchaquíes, and Collas
| Dependent variable | Wichí (LA, | Calchaquíes (IA, | Collas (HA, | Pairwise comparison | Model information |
|---|---|---|---|---|---|
| Age (years) | 42.1±14.1 | 45.9±14.4 | 42.6±13.6 | 1: | Model: |
| 2: | ANOVA | ||||
| 3: | |||||
| Height (cm) | 159.3±8.4 | 158.0±9.1 | 157.5±8.1 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age | ||||
| Weight (kg) | 74.5±15.7 | 65.8±13.2 | 65.5±12.5 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age | ||||
| Body mass index (m2/kg) | 29.4±5.9 | 26.3±4.2 | 26.4±4.5 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age | ||||
| Sitting height (cm) | 82.0±4.2 | 81.9±4.3 | 82.3±4.1 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age, hip circumference | ||||
| Knee height (cm) | 49.3±3.0 | 48.4±3.5 | 46.7±3.3 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age, sitting height, hip circumference | ||||
| Forearm length (cm) | 25.6±1.9 | 25.0±2.2 | 24.5±1.6 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age, height | ||||
| Relative subischial leg length (%) | 48.5±1.6 | 48.1±1.5 | 47.7±1.4 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age | ||||
| Heart rate | 74.3±11.0 | 70.3±9.0 | 71.2±10.5 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age | ||||
| Oxygen saturation (%) | 97.1±1.2 | 92.7±2.4 | 87.4±3.2 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age | ||||
| Respiration rate | 17.5±4.6 | 18.3±3.3 | 21.1±5.6 | 1: | Model: |
| 2: | ANOVA, unequal variances | ||||
| 3: | corrected | ||||
| Vital capacity (L) | 2.6±1.0 | 2.9±1.0 | 2.9±1.1 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age, height | ||||
| Forced vital capacity (L) | 2.9±1.0 | 3.2±1.0 | 3.4±0.9 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age, height, lung health | ||||
| Forced expiratory volume in 1st second (L) | 2.6±0.9 | 2.9±0.9 | 3.0±0.8 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age, height, lung health | ||||
| Peak expiratory flow (L/min) | 4.6±2.0 | 6.3±2.3 | 6.1±2.3 | 1: | Model: |
| 2: | adjusted | ||||
| 3: | IVs: Gender, age, height, lung health |
Pairwise comparisons: 1: Calchaquíes vs. Collas, 2: Calchaquíes vs. Wichí, 3: Collas vs. Wichí.
IVs = Independent variables; Levene's test for homogeneity of variances was nonsignificant, apart for heart rate (P = 0.034) and respiration rate (P = 0.017). Unequal variances were accounted for with the post hoc test Games-Howell in ANOVA. Gender and age had no significant influence on respiration rate. Values are means and standard variation.
Hypoxia related top 1% PBS genes in Calchaquíes
| Rank | Gene | Name | Function | Hypoxia association | Window PBS MAX: Gene PBSMAX |
|---|---|---|---|---|---|
| 5 and 38 | Protein kinase, cGMP-dependent | Key enzyme in NO pathway, regulates platelet activation and adhesion, smooth muscle contraction, cardiac function | NO stimulates guanylate cyclase | 0.836: 0.836; 0.663: also within the gene | |
| 48 | Cystathionine-beta-synthase | Protects neurons against hypoxic injury; regulates cerebral blood flow | Cellular response to hypoxia | 0.631: 0.631 | |
| 264 | Erythropoietin | Regulates erythrocyte production | Cellular response to hypoxia | 0.469: 8 kb downstream (No SNP within the gene) |
213 candidate genes: ACE, ACE2, ADAM8, AGAP3, AGT, AJUBA, AKR1C3, AKT1, ANGPT4, ANKRD1, ANPEP, ANXA1, APEX1, APOA4, AQP1, ARG1, ARNT, ATP6AP2, ATP7A, BACH1, BAD, BBC3, BMP7, BNIP3, CA9, CAT, CBS, CCNB1, CCS, CD34, CD36, CDK1, CDK2, CITED2, CMA1, CPA3, CREBBP, CRYGD, CST3, CTSD, CTSG, CTSZ, CUL2, DPEP1, DUOX1, DUOX2, E2F1, ECT2, EGLN1, EGLN2, EGLN3, EGR1, ENPEP, EP300, EPAS1, EPO, EPX, ETS1, FABP1, FAM162A, FANCC, FBLN5, FER, FIGF, FLT1, FLT4, FMN2, FNDC1, FOS, FOXO1, FXN, GATA6, GNB1, GNGT1, GPX1, GPX3, GUCY1A2, GUCY1A3, GUCY1B2, GUCY1B3, GZMH, HBA1, HBB, HDAC6, HGF, HIF1A, HIF1AN, HIF3A, HIPK2, HMOX1, HP, ICAM1, IL18, IL18BP, IL6, IRAK1, IREB2, ITPR1, KCNK3, KCNMA1, KCNMB1, KCNMB2, KCNMB3, KCNMB4, KDR, KLF2, LCN2, LMNA, LPO, MAP3K5, MAPK7, MDM2, MDM4, MET, MGARP, MME, MPO, MPV17, MRVI1, MT3, MTOR, MYOCD, NDRG1, NET1, NFE2L2, NKX3-1, NOS1, NOS2, NOS3, NOTCH1, NPEPPS, NRP1, NRP2, PARK7, PAX2, PDE10A, PDE11A, PDE1A, PDE1B, PDE2A, PDE3A, PDE3B, PDE5A, PDE6A, PDE6B, PDE6G, PDE9A, PDGFC, PDIA2, PDK1, PDK2, PDK3, PGF, PKD2, PLEKHA1, PLK3, PMAIP1, PPARGC1B, PPIF, PRDX1, PRDX2, PRDX3, PRDX5, PRDX6, PRKAA1, PRKCE, PRKG1, PRKG2, PTGIS, PTGS2, PTPRK, PXDN, PXDNL, PXN, RBX1, REN, RGCC, RHOB, ROMO1, RPS27A, S100B, SFRP1, SFTPC, SIRT1, SLC29A1, SLC8A1, SOD1, SOD2, SOD3, STC1, STC2, TCEB1, TCEB2, TNFAIP3, TP53, TPM1, TPO, TWIST1, TXNRD1, UBA52, UBB, UBC, UBE2D1, UBE2D2, UBE2D3, UBQLN1, UCN2, UCN3, USP19, VEGFA, VEGFB, VEGFC, VHL.
Subset of enriched GO terms of iHS and XP-EHH results in Calchaquíes
| Test (enriched GO terms) | Category | GO term | Enrichment | EASE score |
|---|---|---|---|---|
| iHS (115) | Nitrogen related | Regulation of nitrogen compound metabolic process | 38/1950 | 0.0055 |
| Cellular nitrogen compound metabolic process | 42/2254 | 0.0063 | ||
| Stress response | Response to biotic stimulus | 14/355 | 0.0008 | |
| Response to DNA damage stimulus | 14/379 | 0.0015 | ||
| Defense response | 17/534 | 0.0016 | ||
| Response to stress | 29/1374 | 0.0082 | ||
| Neuron related | Regulation of neuron projection development | 9/168 | 0.0020 | |
| Regulation of neurogenesis | 11/307 | 0.0078 | ||
| Regulation of neuron differentiation | 10/260 | 0.0080 | ||
| XP-EHH (25) | Neuron related | Synaptic transmission, gabaergic | 4/4 | 0.0001 |
| Postsynaptic membrane | 9/164 | 0.0009 | ||
| GABA-A receptor activity | 4/16 | 0.0013 | ||
| GABA signaling pathway | 4/17 | 0.0016 | ||
| GABA receptor activity | 4/19 | 0.0021 | ||
| Synaptic membrane | 9/191 | 0.0023 | ||
| Neuron–neuron synaptic transmission | 5/44 | 0.0024 | ||
| PBS (27) | Neuron related | Neuron differentiation | 2.4 | 0.0053 |
Figure 4Overlap of the top 1% selection test results in Calchaquíes and with the top 5% in Collas. The overlap of windows highlighted by selection tests was the highest for FST with 60%. However, only two out of 213 candidate genes (PRKG1 and CBS) overlapped, both discovered using PBS. PRKG1 ranked higher in Calchaquíes with a PBS score of 0.836 (rank 5) than in Collas with a score of 0.693 (rank 52). Thus, allele frequencies were more diverged in Calchaquíes than in Collas. The PBS score is based on the same SNP (rs10740406) for both populations. CBS ranked lower in Calchaquíes (rank 48, PBS score 0.632) than in Collas (rank 2, PBS score 1.005), indicating a less pronounced allele differentiation in Calchaquíes in comparison to Collas for this gene. For CBS different SNPs within the same 100 kb window were highlighted in the two populations. CBS, cystathionine-beta-synthase; FST, Fixation Index; iHS, integrated Haplotype Score; PBS, Population Branch Score; PRKG1, protein kinase, cGMP-dependent, type I; XP-EHH, Cross Population Extended Haplotype Homozygosity test.